{"id":49456,"date":"2022-10-10T23:02:47","date_gmt":"2022-10-10T21:02:47","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/novanta-inc-schedules-earnings-release-and-conference-call-for-tuesday-november-8-2022\/"},"modified":"2022-10-10T23:02:47","modified_gmt":"2022-10-10T21:02:47","slug":"novanta-inc-schedules-earnings-release-and-conference-call-for-tuesday-november-8-2022","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/novanta-inc-schedules-earnings-release-and-conference-call-for-tuesday-november-8-2022\/","title":{"rendered":"Novanta Inc. Schedules Earnings Release and Conference Call for Tuesday, November 8, 2022"},"content":{"rendered":"<div>\n<p>BEDFORD, Mass.&#8211;(BUSINESS WIRE)&#8211;Novanta Inc. (Nasdaq: NOVT) (the \u201cCompany\u201d), a trusted technology partner to medical and advanced technology equipment manufacturers, will release its third quarter 2022 results on Tuesday, November 8, 2022.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20221010005469\/en\/686477\/5\/novanta_logo_rgb.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20221010005469\/en\/686477\/21\/novanta_logo_rgb.jpg\"><\/a><\/p>\n<p>\nThe Company will host a conference call on Tuesday, November 8, 2022, at 10:00 a.m. ET to discuss these results. To access the call, please dial (888) 346-3959 before the scheduled conference call time. Alternatively, the conference call can be accessed online via a live webcast on the Events &amp; Presentations page of the Investors section of the Company\u2019s website at <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.novanta.com&amp;esheet=52940713&amp;newsitemid=20221010005469&amp;lan=en-US&amp;anchor=www.novanta.com&amp;index=1&amp;md5=6ee3e048e90b4606bfa43b5875df4ba6\" rel=\"nofollow noopener\" shape=\"rect\">www.novanta.com<\/a>.\n<\/p>\n<p>\nA replay of the audio webcast will be available approximately three hours after the conclusion of the call on the Events &amp; Presentations page of the Investors section of the Company\u2019s website at <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.novanta.com&amp;esheet=52940713&amp;newsitemid=20221010005469&amp;lan=en-US&amp;anchor=www.novanta.com&amp;index=2&amp;md5=3ac7a8da3444b079c34c2fbad726faf4\" rel=\"nofollow noopener\" shape=\"rect\">www.novanta.com<\/a>. The replay will remain available until Monday, January 02, 2023.\n<\/p>\n<p>\n<b>About Novanta<\/b>\n<\/p>\n<p>\nNovanta is a leading global supplier of core technology solutions that give healthcare and advanced industrial original equipment manufacturers (&#8220;OEMs&#8221;) a competitive advantage. We combine deep proprietary technology expertise and competencies in photonics, vision, and precision motion with a proven ability to solve complex technical challenges. This enables Novanta to engineer core components and sub-systems that deliver extreme precision and performance, tailored to our customers&#8217; demanding applications. The driving force behind our growth is the team of innovative professionals who share a commitment to innovation and customer success. Novanta&#8217;s common shares are quoted on Nasdaq under the ticker symbol &#8220;NOVT.&#8221;\n<\/p>\n<p>\nMore information about Novanta is available on the Company\u2019s website at <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.novanta.com&amp;esheet=52940713&amp;newsitemid=20221010005469&amp;lan=en-US&amp;anchor=www.novanta.com&amp;index=3&amp;md5=ad4613670bfc60f9bc732eb1fe8cadb1\" rel=\"nofollow noopener\" shape=\"rect\">www.novanta.com<\/a>. For additional information, please contact Novanta Inc. Investor Relations at (781) 266-5137 or <a target=\"_blank\" href=\"&#x6d;&#97;&#x69;&#x6c;&#116;&#x6f;&#58;I&#x6e;&#118;e&#x73;&#116;o&#x72;&#82;e&#x6c;&#97;&#x74;&#x69;&#111;&#x6e;&#x73;&#64;&#x6e;&#111;v&#x61;&#110;t&#x61;&#46;c&#x6f;&#109;\" rel=\"nofollow noopener\" shape=\"rect\">&#x49;n&#x76;&#101;&#x73;&#x74;o&#x72;&#82;&#x65;&#x6c;a&#x74;&#105;&#x6f;&#x6e;s&#x40;&#110;&#x6f;&#x76;a&#x6e;&#116;&#x61;&#x2e;c&#x6f;&#109;<\/a>.\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\n<b>Novanta Inc.<\/b><br \/>Investor Relations:<br \/>\n<br \/>Ray Nash<br \/>\n<br \/>(781) 266-5137\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>BEDFORD, Mass.&#8211;(BUSINESS WIRE)&#8211;Novanta Inc. (Nasdaq: NOVT) (the \u201cCompany\u201d), a trusted technology partner to medical and advanced technology equipment manufacturers, will release its third quarter 2022 results on Tuesday, November 8, 2022. The Company will host a conference call on Tuesday, November 8, 2022, at 10:00 a.m. ET to discuss these results. To access the call, &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/novanta-inc-schedules-earnings-release-and-conference-call-for-tuesday-november-8-2022\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-49456","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Novanta Inc. Schedules Earnings Release and Conference Call for Tuesday, November 8, 2022 - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/novanta-inc-schedules-earnings-release-and-conference-call-for-tuesday-november-8-2022\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Novanta Inc. Schedules Earnings Release and Conference Call for Tuesday, November 8, 2022 - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"BEDFORD, Mass.&#8211;(BUSINESS WIRE)&#8211;Novanta Inc. (Nasdaq: NOVT) (the \u201cCompany\u201d), a trusted technology partner to medical and advanced technology equipment manufacturers, will release its third quarter 2022 results on Tuesday, November 8, 2022. The Company will host a conference call on Tuesday, November 8, 2022, at 10:00 a.m. ET to discuss these results. To access the call, ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/novanta-inc-schedules-earnings-release-and-conference-call-for-tuesday-november-8-2022\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-10-10T21:02:47+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221010005469\/en\/686477\/21\/novanta_logo_rgb.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/novanta-inc-schedules-earnings-release-and-conference-call-for-tuesday-november-8-2022\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/novanta-inc-schedules-earnings-release-and-conference-call-for-tuesday-november-8-2022\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Novanta Inc. Schedules Earnings Release and Conference Call for Tuesday, November 8, 2022\",\"datePublished\":\"2022-10-10T21:02:47+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/novanta-inc-schedules-earnings-release-and-conference-call-for-tuesday-november-8-2022\\\/\"},\"wordCount\":290,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/novanta-inc-schedules-earnings-release-and-conference-call-for-tuesday-november-8-2022\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221010005469\\\/en\\\/686477\\\/21\\\/novanta_logo_rgb.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/novanta-inc-schedules-earnings-release-and-conference-call-for-tuesday-november-8-2022\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/novanta-inc-schedules-earnings-release-and-conference-call-for-tuesday-november-8-2022\\\/\",\"name\":\"Novanta Inc. Schedules Earnings Release and Conference Call for Tuesday, November 8, 2022 - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/novanta-inc-schedules-earnings-release-and-conference-call-for-tuesday-november-8-2022\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/novanta-inc-schedules-earnings-release-and-conference-call-for-tuesday-november-8-2022\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221010005469\\\/en\\\/686477\\\/21\\\/novanta_logo_rgb.jpg\",\"datePublished\":\"2022-10-10T21:02:47+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/novanta-inc-schedules-earnings-release-and-conference-call-for-tuesday-november-8-2022\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/novanta-inc-schedules-earnings-release-and-conference-call-for-tuesday-november-8-2022\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/novanta-inc-schedules-earnings-release-and-conference-call-for-tuesday-november-8-2022\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221010005469\\\/en\\\/686477\\\/21\\\/novanta_logo_rgb.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221010005469\\\/en\\\/686477\\\/21\\\/novanta_logo_rgb.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/novanta-inc-schedules-earnings-release-and-conference-call-for-tuesday-november-8-2022\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Novanta Inc. Schedules Earnings Release and Conference Call for Tuesday, November 8, 2022\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Novanta Inc. Schedules Earnings Release and Conference Call for Tuesday, November 8, 2022 - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/novanta-inc-schedules-earnings-release-and-conference-call-for-tuesday-november-8-2022\/","og_locale":"en_US","og_type":"article","og_title":"Novanta Inc. Schedules Earnings Release and Conference Call for Tuesday, November 8, 2022 - Pharma Trend","og_description":"BEDFORD, Mass.&#8211;(BUSINESS WIRE)&#8211;Novanta Inc. (Nasdaq: NOVT) (the \u201cCompany\u201d), a trusted technology partner to medical and advanced technology equipment manufacturers, will release its third quarter 2022 results on Tuesday, November 8, 2022. The Company will host a conference call on Tuesday, November 8, 2022, at 10:00 a.m. ET to discuss these results. To access the call, ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/novanta-inc-schedules-earnings-release-and-conference-call-for-tuesday-november-8-2022\/","og_site_name":"Pharma Trend","article_published_time":"2022-10-10T21:02:47+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221010005469\/en\/686477\/21\/novanta_logo_rgb.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/novanta-inc-schedules-earnings-release-and-conference-call-for-tuesday-november-8-2022\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/novanta-inc-schedules-earnings-release-and-conference-call-for-tuesday-november-8-2022\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Novanta Inc. Schedules Earnings Release and Conference Call for Tuesday, November 8, 2022","datePublished":"2022-10-10T21:02:47+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/novanta-inc-schedules-earnings-release-and-conference-call-for-tuesday-november-8-2022\/"},"wordCount":290,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/novanta-inc-schedules-earnings-release-and-conference-call-for-tuesday-november-8-2022\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221010005469\/en\/686477\/21\/novanta_logo_rgb.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/novanta-inc-schedules-earnings-release-and-conference-call-for-tuesday-november-8-2022\/","url":"https:\/\/pharma-trend.com\/en\/novanta-inc-schedules-earnings-release-and-conference-call-for-tuesday-november-8-2022\/","name":"Novanta Inc. Schedules Earnings Release and Conference Call for Tuesday, November 8, 2022 - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/novanta-inc-schedules-earnings-release-and-conference-call-for-tuesday-november-8-2022\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/novanta-inc-schedules-earnings-release-and-conference-call-for-tuesday-november-8-2022\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221010005469\/en\/686477\/21\/novanta_logo_rgb.jpg","datePublished":"2022-10-10T21:02:47+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/novanta-inc-schedules-earnings-release-and-conference-call-for-tuesday-november-8-2022\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/novanta-inc-schedules-earnings-release-and-conference-call-for-tuesday-november-8-2022\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/novanta-inc-schedules-earnings-release-and-conference-call-for-tuesday-november-8-2022\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221010005469\/en\/686477\/21\/novanta_logo_rgb.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221010005469\/en\/686477\/21\/novanta_logo_rgb.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/novanta-inc-schedules-earnings-release-and-conference-call-for-tuesday-november-8-2022\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Novanta Inc. Schedules Earnings Release and Conference Call for Tuesday, November 8, 2022"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/49456","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=49456"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/49456\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=49456"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=49456"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=49456"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}